Mismatched Donor Cells to Treat Acute Myeloid Leukemia
NCT01793025
·
clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
12
Enrollment
OTHER
Sponsor class
Conditions
Acute Myeloid Leukemia
Interventions
BIOLOGICAL:
ATAC Therapy
Sponsor
Maisonneuve-Rosemont Hospital